/var/www/fkik/app/lib/SearchEngine/DefaultEngine.php:610 "Search Engine Debug 🔎 🪲"
Engine Type ⚙️: "SLiMS\SearchEngine\DefaultEngine"
SQL ⚙️: array:2 [ "count" => "select count(distinct b.biblio_id) from biblio as b left join mst_publisher as mp on b.publisher_id=mp.publisher_id left join mst_place as mpl on b.publish_place_id=mpl.place_id where b.opac_hide=0 and (b.biblio_id in(select bt.biblio_id from biblio_topic as bt left join mst_topic as mt on bt.topic_id=mt.topic_id where mt.topic like ?))" "query" => "select b.biblio_id, b.title, b.image, b.isbn_issn, b.publish_year, mp.publisher_name as `publisher`, mpl.place_name as `publish_place`, b.labels, b.input_date, b.edition, b.collation, b.series_title, b.call_number from biblio as b left join mst_publisher as mp on b.publisher_id=mp.publisher_id left join mst_place as mpl on b.publish_place_id=mpl.place_id where b.opac_hide=0 and (b.biblio_id in(select bt.biblio_id from biblio_topic as bt left join mst_topic as mt on bt.topic_id=mt.topic_id where mt.topic like ?)) order by b.last_update desc limit 10 offset 980" ]
Bind Value ⚒️: array:1 [ 0 => "%medici%" ]
Abstract Allergic reactions to peanut (Arachis hypogaea, Arah) are caused by immunoglobulin E (IgE)-mediated sensitizations to various proteins. e stability and relative proportion of these proteins in peanut determine the risk of hazardous reactions. Hazardous sensitization to seed storage proteins [S2 albumins (Ara h 2, 6 and 7) > other seed storage proteins (Ara 1 and 3) > oleosins (Ara …
Hintergrund: Die spezi sche Immuntherapie (SIT) induziert allergen-spezi sche IgG Antikörper (Ak), die die Bindung von IgE an Allergen in vitro blockieren können. Bisher ließ sich die Allergen-blockierende Kapazität dieser IgG Ak nur über aufwändige zelluläre Assays nachweisen, die auf der Detektion von Allergen-IgE-Komplexen beruhten, die über den niedrig a - nen IgE-Rezeptor FcRII…
AbstractThe risk of intraperitoneal fragment dissemination of uterine tissue, especially the dissemination of unexpected leiomyosarcoma during electromechanical morcellation, has been increasingly debated during the last year. An improved technique for contained morcellation of uterine tissue inside an insufflated plastic bag during laparoscopy is presented. Twenty-one consecutive containedmorc…
Abstract In laparoscopy, specimens have to be removed from the abdominal cavity. If the trocar opening or the vaginal outlet is insufficient to pass the specimen, the specimen needs to be reduced. The power morcellator is an instrument with a fast rotating cylindrical knife which aims to divide the tissue into smaller pieces or fragments. The Food and Drug Admin-istration (FDA) issued a press r…
Abstract The incidence and severity of endometriosis in ad-olescent are comparable with the incidence in adult women. The mean delay between the onset of symptoms and the final diagnosis varies between 6.4 and 11.7 years. The longer the diagnosis is delayed, the more the endometriosis can progress to a more severe stage certainly in the group of patients with pelvic pain. The evolution of endo…
In a press release in April 2014, the US Food and Drug Administration [1] discourages doctors from using laparoscop-ic power morcellators in removingfibroids or myomatotic uteri in order to reduce the risk of sarcomatous cell escape. The US-based company Johnson & Johnson, the largest manufacturer of the devices, halted global sales and distribution of power morcellators, while many hospitals i…
AbstractThe benefits of fast track regimes, i.e. reduction in hospital stay and minimization of postoperative complica-tions, have led to their widespread use. This study tested the feasibility of a fast track programme based on robot-assisted laparoscopic hysterectomy in which patients were discharged froma day care unit within 6 h after the operation.We enrolled 22 patients. Preoperatively, …
Abstract This was a prospective, longitudinal, multicenter, single-arm controlled trial, using independent core laboratory validation of MRI results, to establish the effectiveness and confirm the safety of the VizAblate® System in the treatment of symptomatic uterine fibroids. The VizAblate System is a transcervical device that ablates fibroids with radiofrequency energy, guided by a built-in…